These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

634 related articles for article (PubMed ID: 29875626)

  • 21. Mitochondrial dysfunction in neurodegenerative diseases and drug targets via apoptotic signaling.
    Wu Y; Chen M; Jiang J
    Mitochondrion; 2019 Nov; 49():35-45. PubMed ID: 31288090
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Role of Mitophagy in Various Neurological Diseases as a Therapeutic Approach.
    Kaur S; Sharma N; Kumar V; Sharma D; Devi B; Kapil L; Singh C; Singh A
    Cell Mol Neurobiol; 2023 Jul; 43(5):1849-1865. PubMed ID: 36326951
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Emerging concepts of mitochondrial dysfunction in Parkinson's disease progression: Pathogenic and therapeutic implications.
    Rani L; Mondal AC
    Mitochondrion; 2020 Jan; 50():25-34. PubMed ID: 31654753
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mitochondrial and Redox-Based Therapeutic Strategies in Huntington's Disease.
    Fão L; Rego AC
    Antioxid Redox Signal; 2021 Mar; 34(8):650-673. PubMed ID: 32498555
    [No Abstract]   [Full Text] [Related]  

  • 25. Mitochondrial fission in Huntington's disease mouse striatum disrupts ER-mitochondria contacts leading to disturbances in Ca
    Cherubini M; Lopez-Molina L; Gines S
    Neurobiol Dis; 2020 Mar; 136():104741. PubMed ID: 31931142
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potential for therapeutic use of hydrogen sulfide in oxidative stress-induced neurodegenerative diseases.
    Tabassum R; Jeong NY
    Int J Med Sci; 2019; 16(10):1386-1396. PubMed ID: 31692944
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Abnormal Mitochondrial Quality Control in Neurodegenerative Diseases.
    Yan X; Wang B; Hu Y; Wang S; Zhang X
    Front Cell Neurosci; 2020; 14():138. PubMed ID: 32655368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
    Hattori N
    Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autophagy and apoptosis dysfunction in neurodegenerative disorders.
    Ghavami S; Shojaei S; Yeganeh B; Ande SR; Jangamreddy JR; Mehrpour M; Christoffersson J; Chaabane W; Moghadam AR; Kashani HH; Hashemi M; Owji AA; Łos MJ
    Prog Neurobiol; 2014 Jan; 112():24-49. PubMed ID: 24211851
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mitochondrial diseases of the brain.
    Chaturvedi RK; Flint Beal M
    Free Radic Biol Med; 2013 Oct; 63():1-29. PubMed ID: 23567191
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oxidative stress and mitochondrial dysfunction-linked neurodegenerative disorders.
    Islam MT
    Neurol Res; 2017 Jan; 39(1):73-82. PubMed ID: 27809706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Melatonin and Autophagy in Aging-Related Neurodegenerative Diseases.
    Luo F; Sandhu AF; Rungratanawanich W; Williams GE; Akbar M; Zhou S; Song BJ; Wang X
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32998479
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of fibroblasts as a valuable strategy for studying mitochondrial impairment in neurological disorders.
    Olesen MA; Villavicencio-Tejo F; Quintanilla RA
    Transl Neurodegener; 2022 Jul; 11(1):36. PubMed ID: 35787292
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mitochondrial Dysfunction and Biogenesis in Neurodegenerative diseases: Pathogenesis and Treatment.
    Golpich M; Amini E; Mohamed Z; Azman Ali R; Mohamed Ibrahim N; Ahmadiani A
    CNS Neurosci Ther; 2017 Jan; 23(1):5-22. PubMed ID: 27873462
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mitochondrial Quality Control via Mitochondrial Unfolded Protein Response (mtUPR) in Ageing and Neurodegenerative Diseases.
    Cilleros-Holgado P; Gómez-Fernández D; Piñero-Pérez R; Romero-Domínguez JM; Reche-López D; López-Cabrera A; Álvarez-Córdoba M; Munuera-Cabeza M; Talaverón-Rey M; Suárez-Carrillo A; Romero-González A; Sánchez-Alcázar JA
    Biomolecules; 2023 Dec; 13(12):. PubMed ID: 38136659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of Mitophagy in neurodegenerative Diseases and potential tagarts for Therapy.
    Jiao L; Du X; Li Y; Jiao Q; Jiang H
    Mol Biol Rep; 2022 Nov; 49(11):10749-10760. PubMed ID: 35794507
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mitochondrial importance in Alzheimer's, Huntington's and Parkinson's diseases.
    Correia SC; Santos RX; Perry G; Zhu X; Moreira PI; Smith MA
    Adv Exp Med Biol; 2012; 724():205-21. PubMed ID: 22411245
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emerging Promise of Therapeutic Approaches Targeting Mitochondria in Neurodegenerative Disorders.
    Rahman MM; Tumpa MAA; Rahaman MS; Islam F; Sutradhar PR; Ahmed M; Alghamdi BS; Hafeez A; Alexiou A; Perveen A; Ashraf GM
    Curr Neuropharmacol; 2023; 21(5):1081-1099. PubMed ID: 36927428
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deciphering the role of PGC-1α in neurological disorders: from mitochondrial dysfunction to synaptic failure.
    Panes JD; Wendt A; Ramirez-Molina O; Castro PA; Fuentealba J
    Neural Regen Res; 2022 Feb; 17(2):237-245. PubMed ID: 34269182
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Revisiting the Mitochondrial Function and Communication in Neurodegenerative Diseases.
    Wankhede NL; Kale MB; Umare MD; Lokhande S; Upaganlawar AB; Wal P; Taksande BG; Umekar MJ; Khandige PS; Singh B; Sadananda V; Ramniwas S; Behl T
    Curr Pharm Des; 2024; 30(12):902-911. PubMed ID: 38482626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.